Evidence for a relationship between plasminogen activator inhibitor-1 and gamma glutamyl transferase

By Bastard J.-P.   Bruckert E.   Porquet D.   Jardel C.   Ankri A.   Delattre J.   Hainque B.  

Thrombosis Research, Vol. 81, Iss. 2, 1996-01 ,pp. : 271-275

Elsevier

Access to resources Recommend Favorite

Molecular Advances in Plasminogen Activator Inhibitor 1 Interaction with Thrombin and Tissue-Type Plasminogen Activator

By Stoop A.   van Meijer M.   Horrevoets A.J.G.   Pannekoek H.  

Trends in Cardiovascular Medicine, Vol. 7, Iss. 2, 1997-02 ,pp. : 47-51

Elsevier

Access to resources Recommend Favorite

Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models

By Hagiwara H.   Kaizu K.   Uriu K.   Noguchi T.   Takagi I.   Qie Y.L.   Seki T.   Ariga T.  

Thrombosis Research, Vol. 111, Iss. 4, 2003-01 ,pp. : 301-309

Elsevier

Access to resources Recommend Favorite

Relationship Between Lipoprotein(a) Phenotypes and Plaminogen Activator Inhibitor Type 1 in Diabetic Patients

By Hernandez C.   Chacon P.   Garca-Pascual L.   Mesa J.   Simo R.  

Thrombosis Research, Vol. 99, Iss. 2, 2000-07 ,pp. : 119-127

Elsevier

Access to resources Recommend Favorite

Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI

By Erem Cihangir  

Endocrine Journal, Vol. 33, Iss. 3, 2008-06 ,pp. : 270-276

Humana Press, Inc

Access to resources Recommend Favorite